US2021169130A1PendingUtilityA1
Methods of manufacturing an oral composition
Est. expiryDec 9, 2039(~13.4 yrs left)· nominal 20-yr term from priority
Inventors:Darrell Eugene Holton, Jr.Dwayne William BeesonRonald K. HutchensChristopher KellerThomas H. PooleFrank Kelley St. Charles
A24B 13/00A24B 15/243
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure provides for oral compositions comprising a clarified tobacco extract and one or more filler components. In another aspect, the disclosure provides methods of preparing a clarified tobacco extract. Such methods can comprise processing a tobacco extract through at least one ultrafiltration step to provide a filtered tobacco extract and passing the filtered tobacco extract through a solution comprising one or more non-molecularly imprinted polymer (NIP) to provide the clarified tobacco extract.
Claims
exact text as granted — not AI-modified1 . A method for preparing a clarified tobacco extract, the method comprising:
processing a tobacco extract through at least one ultrafiltration step to provide a filtered tobacco extract; and passing the filtered tobacco extract through a solution comprising one or more non-molecularly imprinted polymer (NIP) to provide the clarified tobacco extract.
2 . The method of claim 1 , further comprising providing the tobacco extract by extracting a tobacco material with an aqueous solution.
3 . The method of claim 2 , wherein the tobacco material comprises lamina and stems.
4 . The method of claim 1 , wherein the processing the tobacco extract through at least one ultrafiltration comprises processing through a first ultrafiltration membrane having a nominal molecular weight cut off (NMWCO) of about 50 kda.
5 . The method of claim 4 , wherein the processing the tobacco extract through at least one ultrafiltration further comprises processing through a second ultrafiltration membrane having a NMWCO of about 5 kda.
6 . The method of claim 1 , wherein the clarified tobacco extract comprises nicotine in an amount of about 5% to about 50% by weight based on the total weight of the clarified tobacco extract.
7 . The method of claim 1 , wherein the one or more NIP comprises at least one NIP that is specific for tobacco-specific nitrosamines (TSNAs).
8 . An oral composition comprising: a clarified tobacco extract prepared according to the method of claim 1 , or a derivative of said clarified tobacco extract; and one or more filler components.
9 . The oral composition of claim 8 , wherein the clarified tobacco extract comprises nicotine.
10 . The oral composition of claim 8 , wherein the oral composition is positioned within a pouch.
11 . The oral composition of claim 8 , wherein the oral composition is in the form of a lozenge.
12 . The oral composition of claim 8 , wherein the clarified tobacco extract is substantially translucent.Join the waitlist — get patent alerts
Track US2021169130A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.